Device Endo-Mechanical

Echelon Flex

Payments companies reported to CMS as associated with Echelon Flex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2.9Massociated payments (2023-2025)

4,383clinicians with associated payments

6companies reporting

By year

2023 $1.1M

2024 $1.0M

2025 $802K

Payments reported as associated with Echelon Flex, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Surgery $1.9M

Thoracic Surgery (Cardiothoracic Vascular Surgery) $469K

Colon & Rectal Surgery $260K

Physician Assistant $34K

Obstetrics & Gynecology $31K

Nurse Practitioner $25K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Echelon Flex

These are the largest totals companies reported as associated with Echelon Flex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Elizabeth Dovec	Lakeland, FL	Surgery	$427,213.98
Kelvin Higa	Fresno, CA	Surgery	$143,041.99
David Longcope	Denver, CO	Colon & Rectal Surgery	$116,164.21
Mathew Ninan	Nashville, TN	Surgery	$105,609.92
Christopher Ducoin	Tampa, FL	Surgery	$88,739.06
Daniel Miller	Marietta, GA	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$81,150.57
Farah Husain	Portland, OR	Surgery	$65,644.97
Vadim Zeltsman	Great Neck, NY	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$63,213.19
John Morton	New Haven, CT	Surgery	$53,886.17
Alan Wittgrove	Del Mar, CA	Surgery	$49,056.49

Prescribed Echelon Flex?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.